Neurology and Neurosurgery

Host: Professor Sir John Hardy This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disease.

Host: Marwan Noel Sabbagh, MD, FAAN, CCRI This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disease.

Host: Professor Sir John Hardy This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disease.

Host: Professor Sir John Hardy This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disease.

Host: Marwan Noel Sabbagh, MD, FAAN, CCRI This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disease.

Host: Marwan Noel Sabbagh, MD, FAAN, CCRI This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disease.

Host: Professor Sir John Hardy This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disease.

Host: Marwan Noel Sabbagh, MD, FAAN, CCRI This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disease.

Host: Marwan Noel Sabbagh, MD, FAAN, CCRI This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disease.

Host: Professor Sir John Hardy This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disease.

Guest: Marwan Noel Sabbagh, MD, FAAN, CCRI Autophagy through sigma-1 receptor activation is a novel mechanism of action (MOA) in development for the treatment of Alzheimer’s disease. Join Dr. Marwan Noel Sabbagh as he breaks down this new MOA and recent clinical trial data.

Host: Perry Shieh, MD, PhD Explore this on-demand webcast for an in-depth expert presentation and case discussion. This educational initiative is designed to help neurologists enhance their clinical approach by providing individualized, evidence-based care for adult SMA patients. Gain insights into the latest treatment options, safety and efficacy data, and effective patient communication strategies. Equip yourself with the knowledge to meet the unique clinical and psychosocial needs of adults with SMA and improve patient outcomes.

Guest: Phillip H. Kuo, MD, PhD One of the major changes that's occurred very recently in the field of neurodegenerative disease and Alzheimer's disease, specifically, are the recently approved antibody therapies that remove amyloid from the brain, which is one of the culprit proteins in Alzheimer's disease. To learn more about this presentation from SNMMI 2024, join Dr. Phillip Kuo, Professor of Medical Imaging, Medicine, and Biomedical Engineering at the University of Arizona.

Host: Ashley Baker, MSN, PMHNP Guest: Kathleen Nadeau, PhD Girls and women with ADHD are often underdiagnosed and undertreated compared to boys and men, which puts them at risk of serious issues like unplanned pregnancies, cigarette smoking, and even anxiety and depression. To help us better identify and manage girls and women with ADHD, psychiatric nurse practitioner Ashley Baker speaks with Dr. Kathleen Nadeau, Founder and Clinical Director of the Chesapeake Center for ADHD Learning and Behavioral Health in Bethesda, Maryland.

Guest: Kathleen Nadeau, PhD It’s important to be aware of the different ways ADHD impacts girls and women compared to boys and men, which is why Dr. Kathleen Nadeau is here to help shed light on those differences. Dr. Nadeau is the Founder and Clinical Director of the Chesapeake Center for ADHD Learning and Behavioral Health in Bethesda, Maryland.

Host: Valeria Caso, MD, PhD Guest: Ashkan Shoamanesh, MD How can you improve long-term secondary stroke prevention in patients with a history of noncardioembolic ischemic stroke or transient ischemic attack (TIA)? An understanding of how to apply emerging clinical trial data is critical, as is the evaluation of potential alternative agents that could expand the therapeutic options for these patients. In this activity, our expert faculty will add to your knowledge by reviewing the coagulation cascade and the relevance of inhibiting factors XI and XIa in stroke management.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Kay Davies, PhD, DBE FMedSci FRS Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by the progressive loss of muscle, and it primarily occurs in young boys. And since there’s currently no cure, recent therapeutic advancements are aimed at improving symptoms and patient’s quality of life. Dive in to review the therapeutic landscape with Dr. Charles Turck as he’s joined by Dr. Kay Davies, who’sDr Lee's Professor of Anatomy Emeritus at the University of Oxford.

Host: Robert Shin, MD, FANA, FAAN Guest: Enrique Alvarez, MD, PhD Guest: Jiwon Oh, MD, PhD, FRCPC The field of multiple sclerosis (MS) is evolving at a rapid pace from disease modifying therapies (DMTs) to diagnostic/monitoring tools to fundamental principles that shape how clinicians think about the disease. Though such advancements are welcome, they continue to raise new questions about how to optimize management for individual patients. In this program, real clinicians who treat MS pose their most pressing clinical questions to an expert panel. These specialists then provide their best answers through literature and their own clinical experience.

Host: Ashley Baker, MSN, PMHNP Guest: David Goodman, MD, LFAPA ADHD is a lifelong disorder, but its symptoms like memory and concentration difficulties can often be misinterpreted as normal functions of aging. So to help address this misunderstanding, psychiatric nurse practitioner Ashley Baker speaks with Dr. David Goodman about essential diagnostic and treatment strategies for older adults with ADHD. Dr. Goodman is the Director of the Adult Attention Deficit Disorder Center of Maryland.

Host: Ashley Baker, MSN, PMHNP Guest: Timothy Wilens, M.D. The treatment journey for ADHD typically begins in childhood, but therapy interventions must be modified as our patients transition into adulthood. So how do we support our patients along this continuum? Tune in for a discussion on ADHD treatments and the difficulties that result in a missed pediatric diagnosis with psychiatric nurse practitioner Ashley Baker and Dr. Timothy Wilens, Chief of the Division of Child and Adult Psychiatry at Massachusetts General Hospital and a Professor of Psychiatry at Harvard Medical School.